Takeda Pharmaceutical Company Limited vs Target Corporation
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Takeda Pharmaceutical Company Limited
$68.4B
์์ #226
Target Corporation
$69.4B
์์ #222
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Target Corporation์ด(๊ฐ) 2019๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Takeda Pharmaceutical Company Limited์ด(๊ฐ) 2025๋ ๊น์ง Target Corporation์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Target Corporation์ด(๊ฐ) 2026๋ ๊น์ง Takeda Pharmaceutical Company Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Takeda Pharmaceutical Company Limited | Target Corporation | ์ ๋ |
|---|---|---|---|
| 2026 | $68.4B | $69.4B | Target Corporation |
| 2025 | $50.3B | $43.5B | Takeda Pharmaceutical Company Limited |
| 2024 | $41.6B | $57.7B | Target Corporation |
| 2023 | $38.6B | $59.0B | Target Corporation |
| 2022 | $37.6B | $59.8B | Target Corporation |
| 2021 | $27.3B | $91.0B | Target Corporation |
| 2020 | $31.2B | $68.4B | Target Corporation |
| 2019 | $34.2B | $48.7B | Target Corporation |
| 2018 | $28.0B | $24.3B | Takeda Pharmaceutical Company Limited |
| 2017 | $46.8B | $23.3B | Takeda Pharmaceutical Company Limited |
| 2016 | $34.2B | $24.7B | Takeda Pharmaceutical Company Limited |
| 2015 | $41.4B | $24.0B | Takeda Pharmaceutical Company Limited |
| 2014 | $33.1B | $24.4B | Takeda Pharmaceutical Company Limited |
| 2013 | $30.8B | $19.7B | Takeda Pharmaceutical Company Limited |
| 2012 | $23.7B | $18.0B | Takeda Pharmaceutical Company Limited |
| 2011 | $19.8B | $15.2B | Takeda Pharmaceutical Company Limited |
| 2010 | $22.3B | $17.5B | Takeda Pharmaceutical Company Limited |
| 2009 | $20.5B | $13.9B | Takeda Pharmaceutical Company Limited |
| 2008 | $23.7B | $9.7B | Takeda Pharmaceutical Company Limited |
| 2007 | $32.5B | $13.9B | Takeda Pharmaceutical Company Limited |
| 2006 | $39.6B | $15.7B | Takeda Pharmaceutical Company Limited |
| 2005 | $30.4B | $15.0B | Takeda Pharmaceutical Company Limited |
| 2004 | $24.2B | $14.1B | Takeda Pharmaceutical Company Limited |
| 2003 | $19.6B | $10.4B | Takeda Pharmaceutical Company Limited |
| 2002 | $22.5B | $8.0B | Takeda Pharmaceutical Company Limited |
| 2001 | $26.6B | $10.9B | Takeda Pharmaceutical Company Limited |
| 2000 | $30.0B | $8.5B | Takeda Pharmaceutical Company Limited |